Oakley Capital, through its Fund V, has successfully finalized the acquisition of Flemming Dental, Excent, and Artinorway Group in a strategic carve-out from European Dental Group (EDG). This transaction consolidates three major regional players to form one of the premier independent dental laboratory groups in Europe. The strategic rationale for the move centers on the high degree of fragmentation in the European dental lab market, which presents significant opportunities for value creation through a disciplined buy-and-build strategy. By separating these entities from a broader services provider, the group aims to establish an independent technical leader focused exclusively on the accelerating digitalization of the prosthetic and orthodontic sectors. The partnership focuses on leveraging the acquirer’s expertise in technological innovation and international expansion to scale the group’s existing network across European borders. This integration is designed to accelerate the adoption of cutting-edge CAD/CAM and 3D printing technologies, enhancing precision and delivery speed for its combined base of clinics. This transaction reinforces the group’s standing as a primary enabler of the digital transformation within the oral care supply chain, providing the strategic depth required to achieve global market leadership.

This transaction is part of the Healthcare & Pharma industry, which currently tracks an average EBITDA multiple of 12.8x since the beginning of 2026, 1.8% increase compared to 2025. This data is based on contribution from our growing community, composed of M&A and Private Equity professionals, and has been verified by our team to ensure its accuracy.